Amy­lyx hires new CMO from Ul­tragenyx; Eliot Forster is back as a CEO af­ter F-star sale

→ With Amy­lyx Phar­ma­ceu­ti­cals’ ALS drug in full com­mer­cial swing, the Mass­a­chu­setts start­up has found a re­place­ment for its chief med­ical …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.